The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

Share Price Information for K3 Business Technology Group (KBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.941%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
KBT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - K3 Business Technology Group plc

6 Mar 2012 07:01

RNS Number : 7359Y
K3 Business Technology Group PLC
06 March 2012
 



FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer or person acting in concert making the disclosure:

N A Makeham

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

K3 Business Technology Group Plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Person acting in concert with offeree

(e) Date dealing undertaken:

01/03/2012

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

25p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

903,920

3.18

Nil

(2) Derivatives (other than options):

Nil

Nil

(3) Options and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

903,920

3.18

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

 

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

 

Class of relevant security

Scheme

Number of securities to which option relates

Exercise price per unit

Expiry date

25p Ordinary Shares

Share options - unapproved Scheme

50,000

62.5p

25/06/2013

25p Ordinary Shares

Share options - unapproved

Scheme

60,000

100.0p

07/03/2014

25p Ordinary Shares

Share options - unapproved

Scheme

50,000

94.0p

20/06/2015

25p Ordinary Shares

Share options - unapproved Scheme

75,000

85.0p

02/09/2019

25p Ordinary Shares

Share options - unapproved Scheme

100,000

117.5p

29/06/2020

25p Ordinary Shares

Share options - save as you earn

12,626

118.8p

01/01/2016

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p Ordinary Shares

SIP purchase

 

66

£1.92

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

06/03/2012

Contact name:

Rebecca Smith

Telephone number:

0161 876 4498

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCFELLBLXFBBBV
Date   Source Headline
26th Apr 20247:00 amRNSPosting of Annual Report and Notice of AGM
8th Apr 202410:50 amRNSPDMR Announcement
2nd Apr 20244:00 pmRNSPDMR Announcement
26th Mar 20247:00 amRNSFinal Results
29th Jan 20241:00 pmRNSPDMR Announcement
15th Jan 202410:00 amRNSPDMR Announcement
20th Dec 20237:00 amRNSTrading Update
19th Dec 20238:52 amRNSPDMR Announcement
21st Nov 20237:00 amRNSPDMR Announcement
30th Oct 20237:00 amRNSBoard Changes
30th Aug 20237:00 amRNSInterim Results
21st Jul 20235:50 pmRNSPDMR Announcement
7th Jul 20235:10 pmRNSPDMR Announcement
30th Jun 20235:15 pmRNSPDMR Announcement
23rd Jun 20236:00 pmRNSPDMR Announcement
19th Jun 20237:00 amRNSPDMR Announcement
30th May 20231:30 pmRNSPDMR Announcement
23rd May 202311:15 amRNSResult of AGM
19th May 20235:52 pmRNSHolding(s) in Company
19th May 20235:45 pmRNSPDMR Announcement
19th May 20232:45 pmRNSHolding(s) in Company
18th May 202312:58 pmRNSHolding(s) in Company
18th May 202312:45 pmRNSHolding(s) in Company
18th May 202312:40 pmRNSPDMR Announcement
9th May 20237:28 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
28th Apr 20234:07 pmRNSPosting of Annual Report and Notice of AGM
12th Apr 202312:57 pmRNSDirector/PDMR Shareholding
3rd Apr 20231:30 pmRNSPDMR Announcement
30th Mar 20237:00 amRNSFinal Results
30th Mar 20237:00 amRNSBoard Appointment
7th Mar 20237:00 amRNSLargest Order Win for Flagship Fashion Product
6th Feb 202310:00 amRNSPDMR Announcement
23rd Jan 202311:10 amRNSPDMR Announcement
12th Jan 20237:00 amRNSTrading Update
28th Nov 20225:07 pmRNSHolding(s) in Company
28th Nov 20225:05 pmRNSPDMR Announcement
21st Nov 20225:40 pmRNSPDMR Announcement
14th Nov 202212:50 pmRNSPDMR Announcement
7th Nov 20223:53 pmRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
20th Sep 20224:45 pmRNSPDMR Announcement
12th Sep 20225:31 pmRNSPDMR Announcement
24th Aug 20227:00 amRNSInterim Results
26th Jul 20227:00 amRNSBoard Appointment
19th May 202210:57 amRNSResult of AGM
18th May 20225:27 pmRNSK3 LTIP Option Scheme
16th May 202210:42 amRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.